MARKET

NSPR

NSPR

Inspiremd
NASDAQ
0.7200
+0.0650
+9.92%
After Hours: 0.7200 0 0.00% 19:49 06/26 EDT
OPEN
0.6450
PREV CLOSE
0.6550
HIGH
0.7300
LOW
0.6300
VOLUME
103.28K
TURNOVER
--
52 WEEK HIGH
2.932
52 WEEK LOW
0.6300
MARKET CAP
33.72M
P/E (TTM)
-0.9775
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NSPR last week (0615-0619)?
Weekly Report · 6d ago
Weekly Report: what happened at NSPR last week (0608-0612)?
Weekly Report · 06/15 09:35
InspireMD grants 91,161 restricted shares to six new employees under inducement plan
PUBT · 06/12 20:05
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 06/12 20:05
Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Vertex Pharmaceuticals (VRTX)
TipRanks · 06/11 12:51
InspireMD Reports Strong 30-Day Results From CGUARDIANS II Trial
TipRanks · 06/11 12:36
InspireMD Announces 30-Day Outcomes From CGUARDIANS II Clinical Trial Of CGuard Prime 80cm Implant For Use In Transcarotid Artery Revascularization Procedures
Benzinga · 06/11 12:08
InspireMD says FDA reviews PMA supplement for CGuard Prime 80 cm stent in TCAR use
PUBT · 06/11 12:04
More
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Webull offers InspireMD Inc stock information, including NASDAQ: NSPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NSPR stock methods without spending real money on the virtual paper trading platform.